19
Chapter 5: Renal Allograft Biopsy Wong Hin Seng

Chapter 5: Renal Allograft Biopsy Wong Hin Seng

  • Upload
    sabine

  • View
    37

  • Download
    1

Embed Size (px)

DESCRIPTION

Chapter 5: Renal Allograft Biopsy Wong Hin Seng. Table 5.2.1: Number of renal allograft biopsy, 2004-2010. 4 th MRRB report 2010, Malaysia. Figure 5.2.1: Number of renal allograft biopsy, 2004-2010. Allograft biospy. 200. 180. 160. 140. 120. 100. Number of renal transplant biopsy. 80. - PowerPoint PPT Presentation

Citation preview

Chapter 5:Renal Allograft Biopsy

Wong Hin Seng

Table 5.2.1: Number of renal allograft biopsy, 2004-2010

Year 2004 2005 2006 2007 2008 2009 2010 Total

Number of renal transplant biopsy

52 71 118 124 124 133 180 802

4th MRRB report 2010, Malaysia

Figure 5.2.1: Number of renal allograft biopsy, 2004-2010

4th MRRB report 2010, Malaysia

0

20

40

60

80

100

120

140

160

180

200

2004 2005 2006 2007 2008 2009 2010

Year

Nu

mb

er o

f re

na

l tr

ansp

lan

t b

iop

sy

Allograft biospy

Table 5.2.2: Number of renal allograft biopsy by centre, 2004-2010

4th MRRB report 2010, Malaysia

Table 5.2.3: Renal allograft biopsy by year and age group, rate per million population, 2004-2010

Age group

2004 2005 2006 2007

n % Rate n % Rate n % Rate n % Rate

<15 3 5.8 0.0 0 0.0 0.0 6 5.1 0.1 7 5.6 0.1

15-<25 14 26.9 0.3 15 21.1 0.3 25 21.2 0.5 19 15.3 0.4

25-<35 15 28.8 0.3 11 15.5 0.2 25 21.2 0.6 15 12.1 0.3

35-<45 14 26.9 0.4 23 32.4 0.6 26 22.0 0.7 49 39.5 1.2

45-<55 5 9.6 0.2 12 16.9 0.4 24 20.3 0.8 24 19.4 0.8

55-<65 1 1.9 0.1 8 11.3 0.5 8 6.8 0.5 10 8.1 0.6

>65 0 0.0 0.0 2 2.8 0.2 4 3.4 0.3 0 0.0 0.0

Total 52 100 0.2 71 100 0.3 118 100 0.4 124 100 0.5

4th MRRB report 2010, Malaysia

Continue;

4th MRRB report 2010, Malaysia

Age group

2008 2009 2010 Total

n % Rate n % Rate n % Rate n % Rate

<15 9 7.3 0.1 9 6.8 0.1 8 4.4 0.1 42 5.2 0.1

15-<25 22 17.7 0.4 17 12.8 0.3 21 11.7 0.4 133 16.6 0.4

25-<35 20 16.1 0.4 30 22.6 0.6 29 16.1 0.6 145 18.1 0.5

35-<45 25 20.2 0.6 24 18 0.6 66 36.7 1.6 227 28.3 0.8

45-<55 35 28.2 1.1 36 27.1 1.1 40 22.2 1.2 176 21.9 0.9

55-<65 9 7.3 0.5 16 12 0.9 12 6.7 0.6 64 8 0.5

>65 4 3.2 0.3 1 0.8 0.1 4 2.2 0.3 15 1.9 0.2

Total 124 100 0.5 133 100 0.5 180 100 0.6 802 100 0.4

Figure 5.2.3: Renal allograft biopsy by year and age group, rate per million population, 2004-2010

4th MRRB report 2010, Malaysia

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2004 2005 2006 2007 2008 2009 2010

Year

Rat

e (P

er m

illi

on

po

pu

lati

on

)

<15 15-<25 25-<35 35-<45 45-<55 55-<65 >65

Table 5.3: Indications for renal allograft biopsy, 2004-2010

* Patients may have one or more clinical presentation* 48 patients have no information on clinical presentation (neither urine abnormalities nor graft function)

For 2004, 1 patient has 2 indicationsFor 2006, 4 patients have 2 indicationsFor 2007, 5 patients have 2 indicationsFor 2008, 6 patients have 2 indications

For 2009, 11 patients have 2 indicationsFor 2010, 7 patients have 2 indications

4th MRRB report 2010, Malaysia

Table 5.4: Timing of renal allograft biopsy, 2004-2010 (dates: date of biopsy & date of transplant)

Timing of renal transplant biopsy

 Within 1

week 

>1 week to 1month

> 1month to 3

months

> 3 months to 6 months

> 6months to 1 year

>1 yr post transplant

Total

n % n % n % n % n % n % n %

2004 2 3.8 9 17.3 12 23.1 8 15.4 3 5.8 18 34.6 52 100

2005 1 1.4 9 12.7 8 11.3 12 16.9 6 8.5 35 49.3 71 100

2006 4 3.4 15 12.7 13 11.0 9 7.6 9 7.6 68 57.6 118 100

2007 5 4.0 14 11.3 15 12.1 10 8.1 8 6.5 72 58.1 124 100

2008 6 4.8 13 10.5 17 13.7 8 6.5 11 8.9 69 55.6 124 100

2009 5 3.8 15 11.3 20 15.0 8 6.0 6 4.5 79 59.4 133 100

2010 6 3.3 40 22.2 28 15.6 21 11.7 13 7.2 72 40.0 180 100

Total 29 3.6 115 14.3 113 14.1 76 9.5 56 7.0 413 51.5 802 100

4th MRRB report 2010, Malaysia

Figure 5.4: Timing of renal allograft biopsy, 2004-2010

4th MRRB report 2010, Malaysia

0

10

20

30

40

50

60

70

80

90

2004 2005 2006 2007 2008 2009 2010

Year

NU

mb

er o

f ti

min

g o

f g

raft

bio

psy

Within 1 week >1 week to 1month > 1month to 3 months

> 3 months to 6 months > 6months to 1 year >1 yr post transplant

Table 5.5.1: Biopsy method, 2004-2011

*No data on biopsy technique

4th MRRB report 2010, Malaysia

Figure 5.5.1: Biopsy method (censored for missing data), 2004-2010

4th MRRB report 2010, Malaysia

0.0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1.0

2004 2005 2006 2007 2008 2009 2010

Year

Pro

po

tio

n o

f b

iop

sy

me

tho

d

Blind Not US guided US guided: Real time US guided: Not real-time

Table 5.5.2: Number of passes, 2004-2011

4th MRRB report 2010, Malaysia

Figure 5.5.2: Number of passes, 2004-2011

4th MRRB report 2010, Malaysia

0

10

20

30

40

50

60

70

2004 2005 2006 2007 2008 2009 2010

Year

Pe

rce

nta

ge

(%

)

1 2 3 4 5 6

Table 5.5.3: Number of glomeruli obtained on biopsy, 2004-2010

* No data information on the number of glomeruli

4th MRRB report 2010, Malaysia

Figure 5.5.3: Number of glomeruli obtained on biopsy, 2004-2010

4th MRRB report 2010, Malaysia

0

10

20

30

40

50

60

2004 2005 2006 2007 2008 2009 2010

Year

Pe

rce

nta

ge

(%

)

0 1-9 10-19 >20 Missing/Unknown*

Table 5.5.4: Type of complications, 2004-2011

a Mild complication is defined as presence of gross hematuria, perirenal collection, hematoma, or AVM that do not require interventionb Severe complication is defined as presence of hypotension or complications requiring intervention.

c No data information for complications

4th MRRB report 2010, Malaysia

Figure 5.6: Histological diagnosis, 2004-2010

4th MRRB report 2010, Malaysia

0

10

20

30

40

50

60

2004 2005 2006 2007 2008 2009 2010

Year

Per

cen

tag

e(%

)Acute rejection Borderline rejection Calcineurin inhibitor toxicity

Chronic allograft nephropathy Acute tubular necrosis PTLD**

De novo Recurrent GN Diabetic nephropathy

Others

Table 5.6 Histological diagnosis, 2004-2010

* Patients may have more than 1 diagnosis classification**Post Transplant Lymphoproliferative disease

4th MRRB report 2010, Malaysia